CRNX - Crinetics Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRNX is currently covered by 11 analysts with an average price target of $76.6. This is a potential upside of $29.57 (-8.66%) from yesterday's end of day stock price of $83.86.

Crinetics Pharmaceuticals's activity chart (see below) currently has 112 price targets and 116 ratings on display. The stock rating distribution of CRNX is 92.86% BUY and 7.14% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.31% with an average time for these price targets to be met of 473.18 days.

Highest price target for CRNX is $95, Lowest price target is $52, average price target is $76.6.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 07-Jul-2026. First documented stock forecast 13-Aug-2018.

Currently out of the existing stock ratings of CRNX, 26 are a BUY (92.86%), 2 are a HOLD (7.14%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 14-Feb-2019

$85

$1.42 (1.70%)

$81

10 days ago
(07-Jul-2026)

23/24 (95.83%)

$1.47 (1.76%)

337

Buy Since 07-Jul-2026

$85

$1.42 (1.70%)

10 days ago
(07-Jul-2026)

1/2 (50%)

$1.47 (1.76%)

356

Buy Since 30-Mar-2023

$85

$1.42 (1.70%)

$62

10 days ago
(07-Jul-2026)

6/7 (85.71%)

$1.47 (1.76%)

325

Buy Since 19-Mar-2024

$85

$1.42 (1.70%)

$85

10 days ago
(07-Jul-2026)

3/5 (60%)

$1.47 (1.76%)

300

Buy Since 31-Aug-2023

$84

10 days ago
(07-Jul-2026)

9/11 (81.82%)

$47.45 (129.82%)

385

Show more analysts

Please expand the browser size to see the chart

What is CRNX (Crinetics Pharmaceuticals) average time for price targets to be met?

On average it took 473.18 days on average for the stock forecasts to be realized with a an average price target met ratio 63.31

Which analyst has the current highest performing score on CRNX (Crinetics Pharmaceuticals) with a proven track record?

CATHERINE NOVACK

Which analyst has the most public recommendations on CRNX (Crinetics Pharmaceuticals)?

Catherine Novack works at JONESTRADING and has 6 price targets and 7 ratings on CRNX

Which analyst is the currently most bullish on CRNX (Crinetics Pharmaceuticals)?

Josh Schimmer with highest potential upside - $66.33

Which analyst is the currently most reserved on CRNX (Crinetics Pharmaceuticals)?

Jessica Fye with lowest potential downside - -$31.58

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?